Niagen Bioscience Stock Alpha and Beta Analysis
| NAGE Stock | 6.45 0.20 3.20% |
This module allows you to check different measures of market premium (i.e., alpha and beta) for all equities such as Niagen Bioscience. It also helps investors analyze the systematic and unsystematic risks associated with investing in Niagen Bioscience over a specified time horizon. Remember, high Niagen Bioscience's alpha is almost always a sign of good performance; however, a high beta will depend on investors' risk tolerance level and may signal increased volatility and potential future overvaluation. Key technical indicators related to Niagen Bioscience's market risk premium analysis include:
Beta 1.03 | Alpha (0.36) | Risk 2.29 | Sharpe Ratio (0.09) | Expected Return (0.21) |
Enterprise Value |
|
Alpha is a measure of relative performance on a risk-adjusted basis, while beta measures volatility against the benchmark. The goal is to know if an investor is being compensated for the volatility risk taken. The return on investment might be better than its reference but still not compensate for the assumption of the risk.
Check out Niagen Bioscience Backtesting, Niagen Bioscience Valuation, Niagen Bioscience Correlation, Niagen Bioscience Hype Analysis, Niagen Bioscience Volatility, Niagen Bioscience History and analyze Niagen Bioscience Performance. Niagen Bioscience Market Premiums
Investors always prefer to have the highest possible return on investment, coupled with the lowest possible volatility. Niagen Bioscience market risk premium is the additional return an investor will receive from holding Niagen Bioscience long position in a well-diversified portfolio. The market premium is part of the Capital Asset Pricing Model (CAPM), which most analysts and investors use to calculate the acceptable rate of return on investment in Niagen Bioscience. At the center of the CAPM is the concept of risk and reward, which is usually communicated by investors using alpha and beta measures. Alpha and beta are two of the key measurements used to evaluate Niagen Bioscience's performance over market.| α | -0.36 | β | 1.03 |
Niagen Bioscience expected buy-and-hold returns
Although buy-and-hold investment strategy may not appeal to all investors, it may be used as a good measure of Niagen Bioscience's Buy-and-hold return. Our buy-and-hold chart shows how Niagen Bioscience performed over your current time horizon against a typical interest-earning bank account and a selected benchmark.Niagen Bioscience Market Price Analysis
Market price analysis indicators help investors to evaluate how Niagen Bioscience stock reacts to ongoing and evolving market conditions. The investors can use it to make informed decisions about market timing, and determine when trading Niagen Bioscience shares will generate the highest return on investment. By understating and applying Niagen Bioscience stock market price indicators, traders can identify Niagen Bioscience position entry and exit signals to maximize returns.
Niagen Bioscience Return and Market Media
The median price of Niagen Bioscience for the period between Wed, Oct 8, 2025 and Tue, Jan 6, 2026 is 6.89 with a coefficient of variation of 5.96. The daily time series for the period is distributed with a sample standard deviation of 0.41, arithmetic mean of 6.94, and mean deviation of 0.36. The Stock received substential amount of media coverage during this period. Price Growth (%) |
| Timeline |
1 | Niagen Bioscience, Inc. Reports Third Quarter 2025 Financial Results and Reaffirms Increased Full Year Outlook | 11/04/2025 |
2 | Niagen Bioscience Announces 10 Million Share Repurchase Program | 11/06/2025 |
3 | Niagen Bioscience, Inc. Beat Analyst Estimates See What The Consensus Is Forecasting For Next Year | 11/07/2025 |
4 | We Think Niagen Biosciences Profit Is Only A Baseline For What They Can Achieve | 11/11/2025 |
5 | Shareholders Can Be Confident That Niagen Biosciences Earnings Are High Quality | 11/13/2025 |
6 | Niagen Bioscience CFO Acquires 4,465 Shares - MarketBeat | 11/18/2025 |
7 | How Niagen Bioscience Inc. stock behaves under inflation pressure - Gold Moves Low Risk High Reward Trade Ideas - Newser | 12/04/2025 |
8 | Why Niagen Bioscience Inc. stock stays undervalued - 2025 Market WrapUp Free Expert Verified Stock Movement Alerts - | 12/19/2025 |
9 | Niagen Bioscience Why Discipline Matters In A Crowded Supplement Market - Seeking Alpha | 01/05/2026 |
About Niagen Bioscience Beta and Alpha
For many years both, Alpha and Beta indicators are used by professional money managers as critical performance measurement tools across virtually all financial instruments including Niagen or other stocks. Alpha measures the amount that position in Niagen Bioscience has returned in comparison to a selected market index or another relevant benchmark. In other words, Alpha is the excess return on an investment relative to the performance of your selected benchmark. Beta, on the other hand, measures the relative risk of your investment.
| 2023 | 2024 | 2025 | 2026 (projected) | Days Sales Outstanding | 22.86 | 28.47 | 32.74 | 47.42 | PTB Ratio | 3.54 | 9.84 | 11.32 | 10.75 |
Niagen Bioscience Investors Sentiment
The influence of Niagen Bioscience's investor sentiment on the probability of its price appreciation or decline could be a good factor in your decision-making process regarding taking a position in Niagen. The overall investor sentiment generally increases the direction of a stock movement in a one-year investment horizon. However, the impact of investor sentiment on the entire stock market does not have solid backing from leading economists and market statisticians.
Investor biases related to Niagen Bioscience's public news can be used to forecast risks associated with an investment in Niagen. The trend in average sentiment can be used to explain how an investor holding Niagen can time the market purely based on public headlines and social activities around Niagen Bioscience. Please note that most equities that are difficult to arbitrage are affected by market sentiment the most.
Niagen Bioscience's market sentiment shows the aggregated news analyzed to detect positive and negative mentions from the text and comments. The data is normalized to provide daily scores for Niagen Bioscience's and other traded tickers. The bigger the bubble, the more accurate is the estimated score. Higher bars for a given day show more participation in the average Niagen Bioscience's news discussions. The higher the estimated score, the more favorable is the investor's outlook on Niagen Bioscience.
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Niagen Bioscience in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Niagen Bioscience's short interest history, or implied volatility extrapolated from Niagen Bioscience options trading.
Build Portfolio with Niagen Bioscience
Your optimized portfolios are the building block of your wealth. We provide an intuitive interface to determine which securities in a portfolio should be removed or rebalanced to achieve better diversification, find the right mix of securities that minimizes portfolio risk for a given return, or maximize portfolio expected return for a given risk level.Build Diversified Portfolios
Align your risk with return expectations
Check out Niagen Bioscience Backtesting, Niagen Bioscience Valuation, Niagen Bioscience Correlation, Niagen Bioscience Hype Analysis, Niagen Bioscience Volatility, Niagen Bioscience History and analyze Niagen Bioscience Performance. For information on how to trade Niagen Stock refer to our How to Trade Niagen Stock guide.You can also try the Stock Screener module to find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook..
Niagen Bioscience technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.